Literature DB >> 18973498

T-wave alternans: reviewing the clinical performance, understanding limitations, characterizing methodologies.

Euler de Vilhena Garcia1.   

Abstract

Accurate recognition of individuals at higher immediate risk of sudden cardiac death (SCD) is still an open question. The fortuitous nature of acute cardiovascular events just does not seem to fit the well-known model of ventricular tachycardia/fibrillation induction in a static arrhythmogenic substrate by a synchronous trigger. On the mechanism of SCD, a dynamical electrical instability would better explain the rarity of the simultaneous association of a correct trigger and an appropriate cardiac substrate. Several studies have been conducted trying to measure this cardiac electrical instability (or any valid surrogate) in an ECG beat stream. Among the current possible candidates we can number QT prolongation, QT dispersion, late potentials, T-wave alternans (TWA), and heart rate turbulence. This article reviews the particular role of TWA in the current cardiac risk stratification scenario. TWA findings are still heterogeneous, ranging from very good to nearly null prognostic performance depending on the clinical population observed and clinical protocol in use. To fill the current gaps in the TWA base of knowledge, practitioners, and researchers should better explore the technical features of the several technologies available for TWA evaluation and pay greater attention to the fact that TWA values are responsive to several factors other than medications. Information about the cellular and subcellular mechanisms of TWA is outside the scope of this article, but the reader is referred to some of the good papers available on this topic whenever this extra information could help the understanding of the concepts and facts covered herein.

Entities:  

Mesh:

Year:  2008        PMID: 18973498      PMCID: PMC6932058          DOI: 10.1111/j.1542-474X.2008.00254.x

Source DB:  PubMed          Journal:  Ann Noninvasive Electrocardiol        ISSN: 1082-720X            Impact factor:   1.468


  99 in total

1.  Non-invasive cardiac electrophysiological indices in soccer players with mitral valve prolapse.

Authors:  Nikolaos A Koutlianos; Evangelia J Kouidi; Thomas I Metaxas; Asterios P Deligiannis
Journal:  Eur J Cardiovasc Prev Rehabil       Date:  2004-10

Review 2.  Mechanisms of sudden cardiac death.

Authors:  Michael Rubart; Douglas P Zipes
Journal:  J Clin Invest       Date:  2005-09       Impact factor: 14.808

3.  Sudden adult death syndrome and other non-ischaemic causes of sudden cardiac death.

Authors:  A Fabre; M N Sheppard
Journal:  Heart       Date:  2005-05-27       Impact factor: 5.994

4.  Upsurge in T-wave alternans and nonalternating repolarization instability precedes spontaneous initiation of ventricular tachyarrhythmias in humans.

Authors:  Vladimir Shusterman; Anna Goldberg; Barry London
Journal:  Circulation       Date:  2006-06-19       Impact factor: 29.690

5.  Exercise is superior to pacing for T wave alternans measurement in subjects with chronic coronary artery disease and left ventricular dysfunction.

Authors:  Eric J Rashba; Ahmed F Osman; Karen MacMurdy; Malcolm M Kirk; Samantha Sarang; Robert W Peters; Stephen R Shorofsky; Michael R Gold
Journal:  J Cardiovasc Electrophysiol       Date:  2002-09

6.  Combined prognostic value of peak O(2) uptake and microvolt level T-wave alternans in patients with idiopathic dilated cardiomyopathy.

Authors:  Massimo Baravelli; Cecilia Fantoni; Silvia Rogiani; Stefania Farina; Claudio Anzà; Valeria Caltabiano; Teresio Forzani; Jorge A Salerno-Uriarte
Journal:  Int J Cardiol       Date:  2006-12-26       Impact factor: 4.164

7.  Quantitative assessment of microvolt T-wave alternans in patients with congestive heart failure.

Authors:  Thomas Klingenheben; Pawel Ptaszynski; Stefan H Hohnloser
Journal:  J Cardiovasc Electrophysiol       Date:  2005-06

8.  Intravenous administration of class I antiarrhythmic drug induced T wave alternans in an asymptomatic Brugada syndrome patient.

Authors:  Kimie Ohkubo; Ichiro Watanabe; Yasuo Okumura; Takeshi Yamada; Riko Masaki; Tatsuya Kofune; Naohiro Oshikawa; Yuji Kasamaki; Satoshi Saito; Yukio Ozawa; Katsuo Kanmatsuse
Journal:  Pacing Clin Electrophysiol       Date:  2003-09       Impact factor: 1.976

9.  Microvolt T-wave alternans distinguishes between patients likely and patients not likely to benefit from implanted cardiac defibrillator therapy: a solution to the Multicenter Automatic Defibrillator Implantation Trial (MADIT) II conundrum.

Authors:  Daniel M Bloomfield; Richard C Steinman; Pearila B Namerow; Michael Parides; Jorge Davidenko; Elizabeth S Kaufman; Timothy Shinn; Anne Curtis; John Fontaine; Douglas Holmes; Andrea Russo; Chuen Tang; J Thomas Bigger
Journal:  Circulation       Date:  2004-09-27       Impact factor: 29.690

10.  The immediate reproducibility of T wave alternans during bicycle exercise.

Authors:  Daniel M Bloomfield; Brooke S Ritvo; Michael K Parides; Michael H Kim
Journal:  Pacing Clin Electrophysiol       Date:  2002-08       Impact factor: 1.976

View more
  4 in total

Review 1.  Usefulness of T-wave alternans in sudden death risk stratification and guiding medical therapy.

Authors:  Tuomo Nieminen; Richard L Verrier
Journal:  Ann Noninvasive Electrocardiol       Date:  2010-07       Impact factor: 1.468

2.  Assessment of physiological amplitude, duration, and magnitude of ECG T-wave alternans.

Authors:  Laura Burattini; Wojciech Zareba; Roberto Burattini
Journal:  Ann Noninvasive Electrocardiol       Date:  2009-10       Impact factor: 1.468

Review 3.  Minimizing repolarization-related proarrhythmic risk in drug development and clinical practice.

Authors:  Attila S Farkas; Stanley Nattel
Journal:  Drugs       Date:  2010-03-26       Impact factor: 9.546

Review 4.  Anticancer drugs-related QTc prolongation, torsade de pointes and sudden death: current evidence and future research perspectives.

Authors:  Jialin Duan; Jingwen Tao; Maocai Zhai; Chengpeng Li; Ning Zhou; Jiagao Lv; Lin Wang; Li Lin; Rong Bai
Journal:  Oncotarget       Date:  2018-05-22
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.